Gibbs Cancer Center and Research Institute Pelham

Greer, South Carolina 29651

1 studies enrolling now · 2 studies all time

What they study most

Metastatic Castration-resistant Prostate Neoplasms, Triple Negative Breast Cancer

Studies at this site

• A Study of Pasritamig Versus Placebo in Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC) — Recruiting now
• Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo — Running, not enrolling